Clinical Trial Design and Development Work Group Within the Quantitative Imaging Network

Ella F. Jones; John M. Buatti; Hui-Kuo Shu; Richard L. Wahl; Brenda F. Kurland; Hannah M. Linden; David A. Mankoff; Daniel L. Rubin; Darrell Tata; Robert J. Nordstrom; Lubomir Hadjiyski; Matthias Holdhoff; Lawrence H. Schwartz

doi:10.18383/j.tom.2019.00022

Back

Clinical Trial Design and Development Work Group Within the Quantitative Imaging Network

Journal article

Open access

Peer reviewed

Clinical Trial Design and Development Work Group Within the Quantitative Imaging Network

Ella F. Jones, John M. Buatti, Hui-Kuo Shu, Richard L. Wahl, Brenda F. Kurland, Hannah M. Linden, David A. Mankoff, Daniel L. Rubin, Darrell Tata, Robert J. Nordstrom, …

Tomography (Ann Arbor), Vol.6(2), pp.60-64

06/01/2020

DOI: 10.18383/j.tom.2019.00022

PMCID: PMC7289239

PMID: 32548281

Files and links (1)

url

https://doi.org/10.18383/j.tom.2019.00022View

Published (Version of record) Open Access

Abstract

The Clinical Trial Design and Development Working Group within the Quantitative Imaging Network focuses on providing support for the development, validation, and harmonization of quantitative imaging (QI) methods and tools for use in cancer clinical trials. In the past 10 years, the Group has been working in several areas to identify challenges and opportunities in clinical trials involving QI and radiation oncology. The Group has been working with Quantitative Imaging Network members and the Quantitative Imaging Biomarkers Alliance leadership to develop guidelines for standardizing the reporting of quantitative imaging. As a validation platform, the Group led a multireader study to test a semi-automated positron emission tomography quantification software. Clinical translation of QI tools cannot be possible without a continuing dialogue with clinical users. This article also highlights the outreach activities extended to cooperative groups and other organizations that promote the use of QI tools to support clinical decisions.

Clinical Trial Design and Development (CTDD)

Quantitative Imaging Network (QIN)

Review

Details

Title: Subtitle: Clinical Trial Design and Development Work Group Within the Quantitative Imaging Network
Creators: Ella F. Jones - University of California, San Francisco
John M. Buatti - University of Iowa
Hui-Kuo Shu - Emory University
Richard L. Wahl - Washington University in St. Louis
Brenda F. Kurland - University of Pittsburgh
Hannah M. Linden - University of Washington
David A. Mankoff - University of Pennsylvania
Daniel L. Rubin - Stanford University
Darrell Tata - Cancer Imaging Program, National Cancer Institute, Bethesda, MD.
Robert J. Nordstrom - Cancer Imaging Program, National Cancer Institute, Bethesda, MD.
Lubomir Hadjiyski - University of Michigan–Ann Arbor
Matthias Holdhoff - Sidney Kimmel Comprehensive Cancer Center
Lawrence H. Schwartz - Irving Medical Center, Columbia University, New York Presbyterian Hospital, New York, NY
Resource Type: Journal article
Publication Details: Tomography (Ann Arbor), Vol.6(2), pp.60-64
DOI: 10.18383/j.tom.2019.00022
PMID: 32548281
PMCID: PMC7289239
NLM abbreviation: Tomography
ISSN: 2379-1381
eISSN: 2379-139X
Publisher: Grapho Publications, LLC
Language: English
Date published: 06/01/2020
Academic Unit: Radiation Oncology; Neurosurgery; Otolaryngology
Record Identifier: 9984303907402771

Metrics

14 Record Views

1 Times Cited - Web of Science

See more details